Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 14, 2012; 18(2): 126-135
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.126
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.126
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin
Fei Ye, Gui-Hong Zhang, Bao-Xiang Guan, Xiao-chun Xu, Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States
Gui-Hong Zhang, Xiao-Chun Xu, Department of Pathology, Anhui Medical University, Hefei 230032, Anhui Province, China
Author contributions: Ye F, Zhang GH and Guan BX performed the experiments and data analysis; Xu XC designed the experiments, interpreted the data, and wrote the manuscript; Ye F and Zhang GH contributed equally to this work.
Supported by A United States National Cancer Institute Grant, No. R01 CA117895; and a grant from the Duncan Family Institute for Cancer Prevention and Risk Assessment, UT MD Anderson Cancer Center
Correspondence to: Dr. Xiao-Chun Xu, Department of Clinical Cancer Prevention, Unit 1360, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, United States. xxu@mdanderson.org
Telephone: +1-713-7452940 Fax: +1-713- 5635747
Received: May 24, 2011
Revised: July 28, 2011
Accepted: August 4, 2011
Published online: January 14, 2012
Revised: July 28, 2011
Accepted: August 4, 2011
Published online: January 14, 2012
Core Tip